{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:22:14Z","timestamp":1752981734550},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T00:00:00Z","timestamp":1662249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T00:00:00Z","timestamp":1662249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11033-022-07706-5","type":"journal-article","created":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T10:02:15Z","timestamp":1662285735000},"page":"9137-9145","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Downregulation of the paired box gene 3 inhibits the progression of skin cutaneous melanoma by inhibiting c-MET tyrosine kinase"],"prefix":"10.1007","volume":"49","author":[{"given":"Kun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoxi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wancong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,4]]},"reference":[{"issue":"3","key":"7706_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"7706_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/annonc\/mdz011","volume":"30","author":"O Hamid","year":"2019","unstructured":"Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R et al (2019) Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann Oncol 30(4):582\u2013588. https:\/\/doi.org\/10.1093\/annonc\/mdz011","journal-title":"Ann Oncol"},{"issue":"1\u20132","key":"7706_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0163-7258(94)90063-9","volume":"61","author":"P Tremblay","year":"1994","unstructured":"Tremblay P, Gruss P (1994) Pax: genes for mice and men. Pharmacol Ther 61(1\u20132):205\u2013226. https:\/\/doi.org\/10.1016\/0163-7258(94)90063-9","journal-title":"Pharmacol Ther"},{"issue":"2","key":"7706_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ajmg.1320580205","volume":"58","author":"CT Baldwin","year":"1995","unstructured":"Baldwin CT, Hoth CF, Macina RA, Milunsky A (1995) Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature. Am J Med Genet 58(2):115\u2013122. https:\/\/doi.org\/10.1002\/ajmg.1320580205","journal-title":"Am J Med Genet"},{"issue":"5","key":"7706_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1083\/jcb.200211021","volume":"161","author":"P Rajan","year":"2003","unstructured":"Rajan P, Panchision DM, Newell LF, Mckay RD (2003) BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 161(5):911\u2013921. https:\/\/doi.org\/10.1083\/jcb.200211021","journal-title":"J Cell Biol"},{"issue":"6","key":"7706_CR6","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1172\/JCI33715","volume":"118","author":"M Wu","year":"2008","unstructured":"Wu M, Li J, Engleka KA, Zhou B, Lu MM, Plotkin JB et al (2008) Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice. J Clin Invest 118(6):2076\u20132087. https:\/\/doi.org\/10.1172\/JCI33715","journal-title":"J Clin Invest"},{"issue":"6A","key":"7706_CR7","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/j.1582-4934.2008.00427.x","volume":"12","author":"Q Wang","year":"2008","unstructured":"Wang Q, Fang WH, Krupinski J, Kumar S, Slevin M, Kumar P (2008) Pax genes in embryogenesis and oncogenesis. J Cell Mol Med 12(6A):2281\u20132294. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00427.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"7706_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1755-148X.2010.00667.x","volume":"23","author":"JB Mascarenhas","year":"2010","unstructured":"Mascarenhas JB, Littlejohn EL, Wolsky RJ, Young KP, Nelson M, Salgia R et al (2010) PAX3 and SOX10 activate MET receptor expression in melanoma. Pigment Cell Melanoma Res 23(2):225\u2013237. https:\/\/doi.org\/10.1111\/j.1755-148X.2010.00667.x","journal-title":"Pigment Cell Melanoma Res"},{"issue":"W1","key":"7706_CR9","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45(W1):W98\u2013W102. https:\/\/doi.org\/10.1093\/nar\/gkx247","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"7706_CR10","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B (2018) LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res 46(D1):D956\u2013D963. https:\/\/doi.org\/10.1093\/nar\/gkx1090","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"7706_CR11","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong S, Wu WC et al (2019) TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35(20):4200\u20134202. https:\/\/doi.org\/10.1093\/bioinformatics\/btz210","journal-title":"Bioinformatics"},{"key":"7706_CR12","doi-asserted-by":"publisher","first-page":"697471","DOI":"10.3389\/fgene.2021.697471","volume":"12","author":"M Chen","year":"2021","unstructured":"Chen M, Zhang L, Liu X, Ma Z, Lv L (2021) PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer. Front Genet 12:697471. https:\/\/doi.org\/10.3389\/fgene.2021.697471","journal-title":"Front Genet"},{"key":"7706_CR13","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.2147\/OTT.S248085","volume":"13","author":"K Zhang","year":"2020","unstructured":"Zhang K, Tian R, Wang G, Zhang J, Ma H, Hu X et al (2020) ADAMTS8 Inhibits Cell Proliferation and Invasion, and Induces Apoptosis in Breast Cancer. Onco Targets Ther 13:8373\u20138382. https:\/\/doi.org\/10.2147\/OTT.S248085","journal-title":"Onco Targets Ther"},{"key":"7706_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","volume":"4","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Disis ML (2016) Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer 4:59. https:\/\/doi.org\/10.1186\/s40425-016-0165-6","journal-title":"J Immunother Cancer"},{"issue":"24","key":"7706_CR15","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"WJ Clark","year":"1989","unstructured":"Clark WJ, Elder DE, Guerry DT, Braitman LE, Trock BJ, Schultz D et al (1989) Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81(24):1893\u20131904. https:\/\/doi.org\/10.1093\/jnci\/81.24.1893","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"7706_CR16","first-page":"195","volume":"3","author":"PJ Waardenburg","year":"1951","unstructured":"Waardenburg PJ (1951) A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet 3(3):195\u2013253","journal-title":"Am J Hum Genet"},{"issue":"4","key":"7706_CR17","first-page":"983","volume":"48","author":"S Wang-Wuu","year":"1988","unstructured":"Wang-Wuu S, Soukup S, Ballard E, Gotwals B, Lampkin B (1988) Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res 48(4):983\u2013987","journal-title":"Cancer Res"},{"issue":"8","key":"7706_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/2159-8290.CD-16-1297","volume":"7","author":"BE Gryder","year":"2017","unstructured":"Gryder BE, Yohe ME, Chou HC, Zhang X, Marques J, Wachtel M et al (2017) PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. Cancer Discov 7(8):884\u2013899. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1297","journal-title":"Cancer Discov"},{"issue":"8","key":"7706_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/2159-8290.CD-16-1297","volume":"7","author":"BE Gryder","year":"2017","unstructured":"Gryder BE, Yohe ME, Chou HC, Zhang X, Marques J, Wachtel M et al (2017) PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. Cancer Discov 7(8):884\u2013899. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1297","journal-title":"Cancer Discov"},{"issue":"5","key":"7706_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/path.4867","volume":"241","author":"PR Pandey","year":"2017","unstructured":"Pandey PR, Chatterjee B, Olanich ME, Khan J, Miettinen MM, Hewitt SM et al (2017) PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. J Pathol 241(5):626\u2013637. https:\/\/doi.org\/10.1002\/path.4867","journal-title":"J Pathol"},{"issue":"3","key":"7706_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/1078-0432.CCR-11-1981","volume":"18","author":"R Tonelli","year":"2012","unstructured":"Tonelli R, Mcintyre A, Camerin C, Walters ZS, Di Leo K, Selfe J et al (2012) Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy. Clin Cancer Res 18(3):796\u2013807. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1981","journal-title":"Clin Cancer Res"},{"issue":"5","key":"7706_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/path.4867","volume":"241","author":"PR Pandey","year":"2017","unstructured":"Pandey PR, Chatterjee B, Olanich ME, Khan J, Miettinen MM, Hewitt SM et al (2017) PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. J Pathol 241(5):626\u2013637. https:\/\/doi.org\/10.1002\/path.4867","journal-title":"J Pathol"},{"issue":"24","key":"7706_CR23","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1158\/0008-5472.CAN-11-0924","volume":"71","author":"AD Marshall","year":"2011","unstructured":"Marshall AD, Lagutina I, Grosveld GC (2011) PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis. Cancer Res 71(24):7471\u20137480. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0924","journal-title":"Cancer Res"},{"issue":"7","key":"7706_CR24","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1182\/blood-2002-01-0031","volume":"100","author":"J Libura","year":"2002","unstructured":"Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, Kucia M et al (2002) CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 100(7):2597\u20132606. https:\/\/doi.org\/10.1182\/blood-2002-01-0031","journal-title":"Blood"},{"issue":"1","key":"7706_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jcmm.12155","volume":"18","author":"WH Fang","year":"2014","unstructured":"Fang WH, Wang Q, Li HM, Ahmed M, Kumar P, Kumar S (2014) PAX3 in neuroblastoma: oncogenic potential, chemosensitivity and signalling pathways. J Cell Mol Med 18(1):38\u201348. https:\/\/doi.org\/10.1111\/jcmm.12155","journal-title":"J Cell Mol Med"},{"issue":"1","key":"7706_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.21873\/cgp.20113","volume":"16","author":"R Fujii","year":"2019","unstructured":"Fujii R, Osaka E, Sato K, Tokuhashi Y (2019) MiR-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21 via PAX3. Cancer Genomics Proteomics 16(1):71\u201379. https:\/\/doi.org\/10.21873\/cgp.20113","journal-title":"Cancer Genomics Proteomics"},{"issue":"4","key":"7706_CR27","doi-asserted-by":"publisher","first-page":"e9977","DOI":"10.1371\/journal.pone.0009977","volume":"5","author":"S Medic","year":"2010","unstructured":"Medic S, Ziman M (2010) PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas). PLoS ONE 5(4):e9977. https:\/\/doi.org\/10.1371\/journal.pone.0009977","journal-title":"PLoS ONE"},{"issue":"5","key":"7706_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1755-148X.2012.01025.x","volume":"25","author":"CM Bailey","year":"2012","unstructured":"Bailey CM, Morrison JA, Kulesa PM (2012) Melanoma revives an embryonic migration program to promote plasticity and invasion. Pigment Cell Melanoma Res 25(5):573\u2013583. https:\/\/doi.org\/10.1111\/j.1755-148X.2012.01025.x","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"7706_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/bjd.12057","volume":"168","author":"AL Reid","year":"2013","unstructured":"Reid AL, Millward M, Pearce R, Lee M, Frank MH, Ireland A et al (2013) Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. Br J Dermatol 168(1):85\u201392. https:\/\/doi.org\/10.1111\/bjd.12057","journal-title":"Br J Dermatol"},{"issue":"1","key":"7706_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/pcmr.12029","volume":"26","author":"F Liu","year":"2013","unstructured":"Liu F, Cao J, Lv J, Dong L, Pier E, Xu GX et al (2013) TBX2 expression is regulated by PAX3 in the melanocyte lineage. Pigment Cell Melanoma Res 26(1):67\u201377. https:\/\/doi.org\/10.1111\/pcmr.12029","journal-title":"Pigment Cell Melanoma Res"},{"issue":"8","key":"7706_CR31","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-19-1668","volume":"81","author":"L Huang","year":"2021","unstructured":"Huang L, Zhai Y, La J, Lui JW, Moore S, Little EC et al (2021) Targeting Pan-ETS Factors Inhibits Melanoma Progression. Cancer Res 81(8):2071\u20132085. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1668","journal-title":"Cancer Res"},{"issue":"2","key":"7706_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131\u2013142. https:\/\/doi.org\/10.1038\/nrm1835","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"7706_CR33","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420\u20131428. https:\/\/doi.org\/10.1172\/JCI39104","journal-title":"J Clin Invest"},{"issue":"7","key":"7706_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.200601018","volume":"172","author":"JM Lee","year":"2006","unstructured":"Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172(7):973\u2013981. https:\/\/doi.org\/10.1083\/jcb.200601018","journal-title":"J Cell Biol"},{"key":"7706_CR35","doi-asserted-by":"publisher","unstructured":"Masuda T, Ueo H, Kai Y, Noda M, Hu Q, Sato K et al (2020) N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study. Int J Mol Sci 21(2). https:\/\/doi.org\/10.3390\/ijms21020511","DOI":"10.3390\/ijms21020511"},{"issue":"3","key":"7706_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"7706_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/2326-6066.CIR-13-0216","volume":"2","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Cantor H (2014) CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful. Cancer Immunol Res 2(2):91\u201398. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0216","journal-title":"Cancer Immunol Res"},{"key":"7706_CR38","doi-asserted-by":"crossref","unstructured":"Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ et al (2018) Pillars Article: IFNgamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. Nature. 2001. 410: 1107\u20131111. J Immunol 201(3):827\u2013831","DOI":"10.1038\/35074122"},{"issue":"19\u201320","key":"7706_CR39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/gad.314617.118","volume":"32","author":"H Gonzalez","year":"2018","unstructured":"Gonzalez H, Hagerling C, Werb Z (2018) Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev 32(19\u201320):1267\u20131284. https:\/\/doi.org\/10.1101\/gad.314617.118","journal-title":"Genes Dev"},{"key":"7706_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2018.00014","volume":"9","author":"A Durgeau","year":"2018","unstructured":"Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F (2018) Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy. Front Immunol 9:14. https:\/\/doi.org\/10.3389\/fimmu.2018.00014","journal-title":"Front Immunol"},{"issue":"22","key":"7706_CR41","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1158\/1078-0432.CCR-15-0685","volume":"21","author":"L Martinez-Lostao","year":"2015","unstructured":"Martinez-Lostao L, Anel A, Pardo J (2015) How Do Cytotoxic Lymphocytes Kill Cancer Cells? Clin Cancer Res 21(22):5047\u20135056. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0685","journal-title":"Clin Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07706-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T12:28:12Z","timestamp":1664281692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07706-5"}},"subtitle":["PAX3 downregulation inhibits melanoma progression"],"short-title":[],"issued":{"date-parts":[[2022,9,4]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["7706"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07706-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,4]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author reports no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Shantou University Medical College (ethics number: 2021-117). Informed consent was obtained from all patients participating in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}